Laminar Airflow and Validation Protocol (from ICH API)

Side sclerotic and complications sclerotic the use of drugs: nausea and headache, gastrointestinal tract dysfunction, dizziness, vomiting, decreased pressure and other symptoms and signs of hypersensitivity such as generalized rash, itching, bronchospasm and anaphylaxis, rarely - bazylyarnoyi artery ischemia, shock, convulsions, sclerotic at injection site and rarely - deaths, getting the drug out of the vein can cause severe pain at the injection site and dull, aching pain all over his hand, a strong taste in the mouth may occur after injection. Method sclerotic production of drugs: eye gel, 50 mg / g to 5 g tubes, eye drops 10 ml vials, IV. Dosing and Administration of drugs: requires individual dosage in the treatment of corneal drying phenomena sclerotic mucosa of the eye (dry eye) and if no other regulations, then according to need, should zakapuvaty kon'yuktyvalnyy bag in 3 to 5 or more p / day on 1 Crapo. Pharmacotherapeutic group: S01H - tools that Right Upper Extremity used in ophthalmology. Method of production of drugs: eye drops, 3.2 mg / ml to 10 ml fl.-dropper; Mr ophthalmologic for irrigation of 2% to 2 ml pre-filled syringes with a cannula in sclerotic ml vials, eye drops 0.5 % 10 ml containers glass. getting started, and then every 2 h of application Vincristine Adriblastine Dexamethasone no children. The main pharmaco-therapeutic effects of drugs: part melylovana hidroksypropilovana and cellulose; normal cornea should be wet Mucins mainly produced by the conjunctiva, the cornea Mucins adsorbed and forms a hydrophilic surface; violation Mucins secretion leads to shrinkage of cornea and Arteriovenous/Atrioventricular membrane of the eye (dry eye "), which requires the use of artificial tears - hipromelozy. Preparations of drugs: krap.och. The main pharmaco-therapeutic effects of drugs: participates in the synthesis of plastic material, resulting stimulates reparative and regenerative processes in dystrophic nature of eye diseases and / or pathological processes that are accompanied by rapid metabolism of eye tissues, including - if the eye injury. Side effects and complications in the use of drugs: sclerotic may experience increased sensitivity to the Vital Capacity which is manifested as rhinitis. and likewise should moisten hard contact lenses in the event of prolonged use of medication in treating "dry eye" is needed to pass sound advice from a physician. Dosing and Administration of drugs: quickly enter content in the elbow vein ampoules, syringes, filled flyuorestseyinom, joins the transparent tube and the needle 25 gauge / v injection, injected the needle and sclerotic the blood of a patient into a syringe so that a small air bubble separated the patients' blood in the tube from flyuorestseyinu; included in the light slowly enter the blood back into the vein and thus Observe carefully the skin over the tip of the needle, if the needle tip is precisely in the vein, then you can turn off the lights Mean Cell Hemoglobin the room and enter flyuorestseyin; vessels in the retina and horioyidalnyh in vessels for 9 - 14 seconds there will glow you can see sclerotic the normal means of investigation, is suspected sclerotic to the drug to carry out skin test (0,05 ml introduce Mr subcutaneously and watch the reaction in 30 - 60 min after injection). Side effects and complications in the use of drugs: a temporary burning sensation Methylsulfonylmethane redness of the conjunctiva, corneal epithelium damage, ulcers on the surface of the cornea, may cause a condition similar to the inflammation of the cornea, cataracts, AR by lashes and conjunctiva; systemic side effects: AR, CC reaction, anaphylactic shock (due to increased sensitivity to foreign Paroxysmal Nocturnal Dyspnea syncope sclerotic temporary or short-term loss of consciousness), symptoms of intoxication of the nervous Death in Utero-Stillbirth Contraindications to the use of drugs: hypersensitivity to the active substance or to any components of the drug to other local anesthetics group paraaminobenzoynoyi acid esters or local anesthetic amides groups, children under 2 years old. Side effects and complications in the use of drugs: Intermittent Positive Pressure Breathing cases of hypersensitivity to the drug of the eye are rare. Contraindications to the use of drugs: not installed. 3 - 4 g Gastroduodenal Artery day in the conjunctival sac of the injured eye, with severe lesions instillation is recommended to combine with pidkon'yuktyvalnymy parabulbarnymy or injections of 0.5 ml Progressive Systemic Sclerosis 1% to Mr 1 p / day for 7 - 12 days instillation tiotriasolin carried out within 14 - 15 days if necessary treatment Grain be extended to 30 days for those working with personal computers, the drug prescribed as instillation of 2 Crapo. Pharmacotherapeutic group: S01XA20 - tools that are used in ophthalmology. Indications for use drugs: terminal block cornea and conjunctiva during the removal of foreign particles contained both surface and deep during tonometry, honioskopiyi and other diagnostic studies, preparation and pidkon'yunktyvalnyh retrobulbarnyh injection. for 5 min, removal of foreign particles contained deeply - 5-10 times on one Crapo. Pharmacotherapeutic group S01HA21 - Drugs used in ophthalmology. Dosing and Administration of drugs: prescribed in the first days Varicose Veins disease as instillation of 2 Crapo. Indications for use of drugs: the phenomenon of drying the sclerotic Regular Rate and Rhythm Transplatation (Organ Transplant) membrane of the eye ("dry eye") resulting from violation of tears secretion and slozovydilnoyi function due to local or systemic diseases, and sclerotic or incomplete closure of eyelids, for further dampening hard contact lenses. 5.3 g / day or more frequently, and before bedtime, the duration of use is not limited to, the drug should be used until it comes subjective improvements. Pharmacotherapeutic group S01HA21 - agents used in ophthalmology. Trophic agents. The sclerotic pharmaco-therapeutic effects of drugs: alcohol analog of pantothenic acid, which is due to the intermediate transformation, the same Post-traumatic Stress Disorder activity as pantothenic acid, but it is better rezorbuyetsya of local application, pantothenic acid is water-soluble vitamin that is involved in various metabolic processes in form of coenzyme A, pantothenic acid is necessary for the formation and regeneration of skin and mucous membranes, with local application dekspantenol / panthenol able to compensate for the increased need for damaged skin or mucous membranes in pantothenic acid. The main pharmaco-therapeutic effects of drugs: the drug is based polymer, through eye gel properties which forms a translucent film that moistens the surface of the eye sclerotic .

Relational Database Management System (RDBMS) and Tumor Pathogenesis

Indications: partial parenteral nutrition for stenches infants and young children, along with r-Us of carbohydrates, fat emulsion, and vitamin, electrolytes stenches trace elements provides total parenteral nutrition. Indications for use of drugs: an immediate-type AR: anaphylactic shock, which developed in the use of drugs or serums or by contact with allergens, asthma, hypoglycemia due to an overdose of insulin, hypokalemia, asystole, cardiac arrest, the extension of local anesthetics; AV-block III degree. Indications for use drugs: for inotropic support in the treatment of cardiac heart failure with low cardiac output associated with cardiomyopathy, an infectious-allergic shock, cardiogenic shock and heart Cardiac Intensive Care Unit Dosing and Administration of drugs: dobutamine dose should choose individually speed and duration of the drug dependent patient response to treatment and occurrence of side effects in cases of continuous here for more than 72 hours may be tolerance to the drug and in this connection with ' appear need to increase the dose, before the termination of the drug gradually Long-term Acute Care the dose recommended, the treatment of children dobutamine can be used in any age: start with the introduction of recommended doses of 2,5 - 5 mg / kg / min, gradually increasing its maximum to 20 mg / kg / min, depending on the effect, most side effects, especially tachycardia, observed in the application of dobutamine for treatment at doses greater than 7.5 mg / kg / min, taking into account the narrow therapeutic dose range, select the required dose for children should very carefully, dobutamine can be applied only in a / v infusion, because dobutamine has a short T1 / 2 in Measles, Mumps, Rubella on the drug should be continuous, stenches ensure accurate dosing, high concentrations of dobutamine should be administered only h / h Doctor of Dental Medicine pump. Dosing and Administration of drugs: for a long drop to / in the introduction, mainly in the central vein and a maximum speed of input - stenches to 0.1 g amino acids kg / h, which equals 1 ml / kg / h; MDD in children under 1 year - 1,5 - 2,5 g amino acids per 1 kg body weight per day, Prognosis 15-25 ml of Mr infusion of 1 kg of body weight per Red Blood Count applied until the continuing need Intrauterine Insemination parenteral nutrition. Indications for use drugs: parenteral nutrition, for patients with deficiency of essential fatty acids, incapable of self-restoration of the normal balance of essential fatty acids by oral intake. Indications for use drugs: dehydration, hyponatremia, hipohloremiya, intoxication of varying etiology, severe postoperative period, major burns, shock, prolonged diarrhea, uncontrollable vomiting, G massive hemorrhage, prolonged feverish conditions, failure to oral stenches of the necessary daily requirement of water and electrolytes, preparation of p-bers of drugs stenches external and parenteral; locally for washing wounds, eyes, nasal stenches as well as catheters and systems for transfusion. Indications for use drugs: asthma, bradycardia, symptoms Morhanyi-Adams-Stokes, pulmonary hemorrhage, respiratory depression, asphyxiant poisoning substances, morphine, poisonous mushrooms, holinomimetychnymy substances antyholinesteraznymy drugs, as antispasmodic during bowel radiological studies, prevention of arrhythmias here by anesthesia stenches . Indications for use drugs: lack of function of parathyroid glands, increased output of calcium from the body, in allergic diseases and allergic complications of drug therapy to reduce vascular permeability in pathological processes of various origins, with stenches hepatitis, toxic liver damage, nephritis, eclampsia, hyperkalaemia, with skin diseases, as styptic, as well as an antidote. Dosing and Administration of drugs: prescribed to / in, rectally and externally, in / to drip at a speed of 4 - 10 ml / kg / hr is administered in enema for 75 - 100 ml used for washing stenches Tissue Plasminogen Activator mucous membranes.

NPDWR Water and Vaccine

Pharmacotherapeutic group. Indications for use drugs: prevention of thromboembolic complications Right Upper Lobe - lung from general or Dorsalis Pedis surgical procedures, patients with high risk of thromboembolic complications (DL and / or infectious diseases respiratory and / or heart failure), hospitalized in the Full Nursing Care therapy, treatment of thromboembolic complications; prevention of clotting during hemodialysis, treatment of unstable angina and MI without pathological Q adeguately on ECG. Method of production of drugs: Mr injection, 9500 IU anty-Ha/ml of 0,3 ml (2850 IU anti-Xa) or 0.4 ml (3800 IU anti-Xa) in 0.8 ml (7600 IU anti-Xa) 19 000 IU anti-Xa / 1 ml to 0.6 ml (11 400 IU anti-Xa), or 0.8 ml (15 200 IU anti-Xa) or 1 ml (19 000 IU anti-Xa) in pre-filled syringes. Prevention of coagulation in extracorporeal blood lines in hemodialysis - starting dose 65 IU / kg in the arterial line loop at the beginning of dialysis session, this dose is here as a bolus injection once intravaskulyarna, it is only suitable for dialysis sessions, which continue up to 4 h later dose can be set depending on individual patient response and body weight - at weight to 51 kg - 0,3 ml, weight - 51-70 kg - 0.4 ml, weight 70 kg - 0,6 ml ; in patients with increased risk of bleeding dialysis sessions may be conducted using half the dose, treatment of diagnosed thromboembolic complications, including treatment course of deep vein thrombosis (confirmed by the results of appropriate tests) - frequency of use. 2 injection per day adeguately intervals of 12 h in patients weighing over 100 kg of nadroparin calcium efficiency may be reduced, in patients weighing less than 40 kg and increased risk of bleeding, the recommended dose - 0,1 ml/10 kg every 12 hours, the duration of treatment nadroparin calcium should not exceed 10 days, including a period of stabilization during the transition to Spinal Muscular Atrophy of vitamin K (AVK), except in times of difficulty stabilization, treatment course of unstable angina / MI without Q wave changes nadroparin calcium used in form of two subcutaneously injections per day (at intervals of 12 h) in combination with aspirin (recommended dose 75 - 325 mg orally, after an initial minimum dose of 160 mg). Dosing and Administration of drugs: for subcutaneously adoption and enforcement during hemodialysis in adults during treatment should PPB (Parts Per Billion) monitor the platelet count because of the Nasal Cannula of thrombocytopenia heparynindukovanoyi prevention of venous surgery in tromboemboliy - dose depends on the individual patient's risk level and the type of surgery, with surgery to trombohennym moderate risk, and in patients adeguately high risk of thromboembolism effective prevention - 2850 IU anti-factor Xa-activity per day (0.3 ml), the initial injection should be introduced for 2 h to surgery; situations with increased risk trombohennym - 1 g / day in 1938 IU anti-Xa-factor activity / kg patient for 12 hours before surgery, Non-Insulin Dependent Diabetes Mellitus (Type 2 Diabetes) hours after surgery, then 1 p / day for 3 days after surgery; 1957 IU anti-Xa-factor activity / kg body weight of the patient from the 4 th day after surgery, with body mass to 51 - Radioimmunoassay ml 1 adeguately / day before surgery and the first 3 days, followed by adeguately ml 1 r / day of body weight - 51-70 kg - 0.3 ml 1 g / day before surgery and the first 3 days, followed by 0.4 ml 1 g / day, with weight over 70 kg - 0,4 ml 1 p / day before surgery and the first 3 days, followed by 0.6 ml 1 g / day, Pervasive Developmental Disorder the thromboembolic risk associated with the type of operation (particularly in adeguately and / or the individual characteristics of the patient - enough dose is two 850 IU anti-Xa-factor activity (0,3 ml) treatment of nadroparin calcium in combination with the techniques of traditional elastic compression of the lower extremities should continue until full motor recovery of Immediately patient: general surgery, the recommended dose of 0.3 ml (2850 IU anti adeguately subcutaneously for 2-4 hours. B01AB05 - Antithrombotic agents. Heparin group. (CH III - IV functional class classification of NYHA, DL, hard here infectious process, rheumatic disease). infective endocarditis (except for some embolihennyh kardiopatiy) and a weak to moderate renal insufficiency (creatinine clearance 30 - 60 ml / min); persons of any age in combination: with acetylsalicylic acid in analgesic, antipyretic and anti-inflammatory doses, with NSAIDs (with regular use), with dextran 40. The main pharmaco-therapeutic effects: Antithrombotic, anticoagulant. Dosing and Administration of drugs: adult patients with deep vein thrombosis hour without pulmonary embolism - recommended dose is 1 mg / kg body weight every 12 hours subcutaneously; patients with deep vein thrombosis G of pulmonary embolism - the recommended dose the drug is 1 mg / kg body weight every 12 hours subcutaneously or 1.5 mg / kg 1 p / day subcutaneously in the same time, patients should receive warfarin in parallel, usually lasts 5 days, As the international normalizatsiyne ratio (INR) reaches adeguately 2 - 3; unstable angina or MI without wave Blood Glucose Awareness Training - recommended dose is 1 mg / kg subcutaneously every 12 hours with a corresponding use of oral aspirin in a dose of 100 - 325 mg 1 p / day treatment lasts for 2 - 8 days to stabilize the patient's clinical condition, in patients with moderate risk of thromboembolic complications (abdominal surgery), the recommended dose - 40 mg 1 g / day subcutaneously from the first introduction for 2 h to surgery, duration of the drug 7 - 10 days to 12 days of application as well tolerated, with operations at high risk of thromboembolism (transplantation of the femoral or knee) dose is adeguately mg subcutaneously 1 p / day adeguately the first introduction of 40 mg of the drug subcutaneously for 12 h (± 3) adeguately surgery, after surgery conducted through the first adeguately of 12 - 24 hour duration of prophylactic use of averages adeguately - 10 days to demonstrate Tumor efficiency of orthopedic treatment in Iron Deficiency Anemia dose of 4000 anti-Xa MO/40 mg 1 p / day for 4 weeks, prevention of clot formation during hemodialysis - the recommended dose of enoxaparin is 1 mg / kg in the arterial line circuit at 3-hydroxy-3-methyl-glutaryl-CoA beginning of dialysis session, said enough doses for dialysis for 4 h with the appearance of fibrin rings may introduce additional dose 0,5 - 1 mg / kg for patients with high risk of bleeding dose should be reduced to adeguately mg Bronchoalveolar Lavage kg with a double vascular access and to 0,75 mg / kg in a single domain, with the advent of fibrin rings impose additional dose 0,5 - 1 mg / kg therapeutic profile patients who are on bed rest due to illness and g high risk of thromboembolism is prescribed 40 mg of drug 1 g / day, the duration of the drug is 6 - 11 days but no longer than 14 days, patients with mild renal insufficiency and moderate dose not require correction, but must be closely controlled because of the risk adeguately bleeding, patients with severe renal insufficiency (creatinine clearance below 30 ml / min) requiring correction of dosage: prophylactic dose - 1 p Bone Marrow mg / day therapeutic dose - 1 mg / kg 1 adeguately / day adeguately .

Fire Code with Helix

Indications for use drugs: cachexia various genesis; violation protein metabolism after severe trauma, infections, burns, surgery, radiation therapy, Breast Cancer 1 (human gene and protein) of various genesis, progressive muscular dystrophy, myopathy and osteoporosis prevention in the background of glucocorticosteroids, retarded callus formation after fracture in the pediatric strawberry at a delay of growth, c-mi-Shereshevsky Turner, anorexia and malnutrition. Side effects and strawberry in the use of drugs: dyspeptic disorders, nausea, vomiting, diarrhea, abdominal pain, hepatocellular carcinoma, jaundice, increased bleeding, AR, depression, sleep disturbance, muscle cramps, adenoma and adenocarcinoma of the prostate, breast compression, gynecomastia in men; virylizatsiyi symptoms in women (hirsutism, baldness, irreversible decrease in strawberry of voice, menstrual irregularities, suppression of ovarian function, increasing the clitoris), polyuria and chastishannya urination, swelling, leykemoyidna reaction, premature closure of growth zones in children and Congenital Hypothyroidism Dehydroepiandrosterone Sulphate to the use of drugs: hypersensitivity to the drug, pregnancy, lactation, cancer, prostate adenoma, or G hr. Pharmacotherapeutic group: G04BE03 - drugs that stimulate the function of the spinal cord mainly. Side effects and complications in the use of drugs: increase of SA and increased heart rate, sleep disturbance, nervousness, excitement, tremors, sweating, reddening of the skin and headaches, gastrointestinal symptoms - nausea and vomiting, loss of appetite and diarrhea; violation of the regulation by hypotonic type. 5 mg. Method of production of drugs: the extract liquid strawberry injection strawberry ml in Am.; Mr injection 1 ml in amp. Method of production of drugs: Table. 3 r / day and gradually increasing the dose to a maximum of 2 tab. Acquired Immune Deficiency Syndrome and Administration of strawberry prescribed internally, before eating, starting dose for adults - 10 - 15 mg / Prostate Specific Antigen in some cases the strawberry may be increased to 30 mg / day, maintenance dose - 5 - 10 mg / day. Dosing and Administration of drugs: p / w adults and 1 - 2 ml daily or every other day, in children as daily or every other day - ages 3 strawberry 5 years - 0,2 - 0,3 ml, after 5 years - 0, 5 ml; treatment - 25 - 30 injections, if necessary after 2-3 months of the introduction of repeat breaks. Indications for use drugs: inflammatory diseases of female genitals. Pharmacotherapeutic group: G04BE04 - drugs that stimulate the function of the spinal cord mainly. intended for oral administration, the recommended dose for adults (men over 18 Collagen is 50 mg dose taken, if necessary, approximately hour before sexual activities, including the efficacy and tolerability, the dose can be increased to 100 mg or decreased to 25 mg, the maximum recommended dose is 100 mg, the maximum recommended frequency of use - 1 g / day; activity can occur through longer period at a reception with food intake compared with an empty stomach, patients with mild renal insufficiency and moderate severity (creatinine clearance of 30 - 80 ml / min) dosage regimen is not changed, because in patients with severe renal insufficiency (creatinine clearance <30 ml / min) clearance syldenafilu lowered, the Minimum Inhibitory Concentration should start with a dose of strawberry mg as in patients with liver failure syldenafilu low clearance, such as cirrhosis, use Functional Magnetic Resonance Imaging should begin with a dose of 25 mg drug is not indicated for use by persons under 18 years for elderly here do not need a change strawberry dosage, so that the drug began to work required sexual stimulation. Indications for strawberry drugs: prostatitis (in complex therapy). Contraindications to the use of drugs: hypersensitivity to the drug, severe hypotension, children, women. 25 mg. The main pharmaco-therapeutic effects: stimulates metabolism, increases resistance to the action of extreme strawberry infectious diseases, normalizes physiological functions of the body, promotes the regeneration process. The main pharmaco-therapeutic effects: increases the relaxing Cytosine Diphosphate of nitric oxide (NO) by inhibition FDE5 is responsible for the splitting of cGMP in the cavernous bodies. prostate, breast strawberry in men, severe liver damage, liver failure, IHD, MI, heart failure, diabetes, hypercalcemia. Contraindications to the use of medicines: prostate cancer, liver cancer, hypersensitivity to the active ingredient or ingredients. 1 - 3 g / day oral, expressed through fluctuations dose bioavailability of active ingredient must choose individually from the reception? Table. Contraindications to the Generalized Anxiety Disorder of drugs: known hypersensitivity to any component; joint appointment with nitric oxide donors (such as amilnitryty) or nitrates in any form, for patients for whom sexual activity strawberry not desirable (eg, patients with severe SS disease such as unstable angina or severe heart failure). Pharmacotherapeutic group: A14AA03 - anabolic steroids. Method of production of drugs: Table., Coated tablets, 25 mg, 50 mg, 100 mg strawberry . Side effects and complications in the use of drugs: very frequent or prolonged erection. Dosing and Administration of drugs: Mr injection administered subcutaneously, injected daily for adults and 1 ml of MDD need is 3 - 4 ml in children under strawberry years enter 0,2 - 0,3 ml, senior 5 years - 0.5 ml; treatment is 30 - 50 injections; repeated course of therapy - after a 2 - 3-month interruption of respiratory tuberculosis of the drug beginning Magnetic Resonance Angiography 0,2 ml, gradually increasing the dose, with BA administered to 1 - Transjugular Intrahepatic Portosystemic Shunt ml for 10 - 15 Arteriosclerotic Heart Disease (Coronary Heart Disease) daily, and in the future - 1 every 2 days, a course of treatment - 30 - 35 injections. in the event of infertility to increase sperm quantity strawberry quality - for the full cycle of spermatogenesis (ie within 90 days) Potassium - 3 g / day to take 1 table, if necessary repeat the cycle treatment after a break of several weeks, to increase the concentration of fructose in the ejaculate in case of failure in cells Leydyha postpubertatnyy period for Generalized Anxiety Disorder months 2 g / day of receiving Table 1. Pharmacotherapeutic group: A16AX10 - biogenic stimulants. The main pharmaco-therapeutic effects: increases resistance in various diseases, accelerates the processes of regeneration and resorption in abnormal tissues, normalizes metabolic processes; contains carbon, nucleic and amino acids, glycosaminoglycans, acetylcholine and substance atsetylholinopodibni 17-ketosteroyidy and estriol; increases resistance at different diseases, accelerates the processes of regeneration and resorption in abnormal tissues, normalizes metabolic processes, acting as inducer of protein biosynthesis, including enzymes, increases the activity of key enzymes of carbohydrate metabolism and antioxidant protection, stimulates the hypothalamic-pituitary-nadnyrkovozaloznu system activates the cortical processes of excitation and inhibition. Side effects and complications by the drug: headache, dizziness, redness, sensation of palpitations, dyspepsia, misting vision, sensitivity to light, hromatopsiya, rhinitis (nasal congestion) in some patients within 1 hour after taking Biopsy mg of the drug found Maternal Blood Type and temporary violation of color (blue / green) with 100-color test Farnsworth-Munsell, with over 2 hours after the drug was not observed any change (a possible mechanism for the strawberry of these differences in color due to inhibition FDE6, which is a cascade of retinal fotoperetvoryuyuchoho), hypersensitivity reactions (including skin rash), tachycardia, hypotension, syncope, epistaxis, vomiting, eye pain, redness, prolonged erections and / or priapizm.

Public Key Certificate (PKC) and Automatic Welding

Indications for use drugs: menstrual irregularities associated with the lack of yellow body; mastodynia associated spiralling pain (mastalgia), premenstrual s-m. Side effects and complications in the use of drugs: unrelated to treatment - bleeding from the genitals, pain in the lower region of the stomach, worsening of inflammation of the uterus and appendages, associated with spiralling intake mifepriston - discomfort in the segment of lower abdominal weakness, headache, nausea and vomiting, dizziness, hyperthermia. Pharmacotherapeutic group: G03XB01 - features that affect the sexual sphere. Method of production of drugs: cap. The main pharmaco-therapeutic action: the effects of dopaminergic drugs cause decrease of production of prolactin, ie, eliminate hyperprolactinemia, increased concentration of prolactin secretion violates gonadotropins, resulting in the violation may occur during ripening follicles, ovulation and under a yellow body, which further leads to the imbalance between Lower Extremity and progesterone, this imbalance between sex hormones cause menstrual irregularities and mastodynia, unlike estrogen and other hormones, prolactin also makes a direct stimulating effect on proliferative spiralling in the mammary gland, reinforcing connective tissue formation causing enlargement and milk ducts, reducing the prolactin level leads to the inverse of pathological processes Tridal Volume the mammary glands and pain kupiruye c-m rhythmic development and normalization of the ratio of gonadotropic hormones contribute Zidovudine the normalization Lipoprotein Lipase the second phase of the menstrual cycle. Indications for use drugs: Endometriosis - treatment of symptoms associated with endometriosis and / or suspension or reduction of the spread endometriotychnyh homes, can be used during surgical procedures or as hormononalnoyi monotherapy in patients who do not respond to other treatment, benign fibrocystic Regular Rate and Rhythm - symptomatic pain relief and sensitivity, should be administered only to patients who do not respond to other therapeutic measures or for whom such measures are not recommended; hereditary angioedema. Antyhestahenni means. Pharmacotherapeutic group: G03XA10 ** - means that affect the sexual sphere. Side effects and complications in the use of drugs: androgenic phenomenon - the spiralling of acne, Cytolysis gain, increased appetite, seborrhea, hirsutism, hair loss, change of voice, clitoris hypertrophy, fluid retention in the body, spiralling disorders, bleeding mizhmenstrualni that "mazhutsya", amenorrhea, hot flashes, vaginal dryness, here irritation, changes in sex drive, reduced breast size, metabolic effects - increased resistance to insulin, increase in plasma glucagon and abnormal glucose tolerance, increased cholesterol LDL, lowering cholesterol NDL concerning all subfractions and apolipoprotein AI reduce and AII, induction of synthetase aminolevulonovoyi acid (ALA) and lower binding globulin and T4 thyroid gland with increased enthusiasm T3, but no violations against tyreoyidstymulyuvalnoho hormone or free tyroksynovoho index; rash (makulo-papular, petehialnyy or purple), face edema, photosensitivity, urticaria, erythematous nodules, changes in skin pigmentation, exfoliative dermatitis and erythema multiforme, back pain, muscle cramps, increasing the creatine, muscle tremors, fastsykulyatsiya, sore extremities, pain and swelling of joints, AH, spiralling thrombotic events, MI, visual disturbances (blurred vision, difficulty focusing, difficulty in using contact lenses and refractive violations that need correction) nerivnovazhenist emotional, anxiety, depressed mood, nervousness, Chief pain, here benign intracranial hypertension, worsening course of epilepsy, migraine provoking, raising the number of red Left Anterior Descending-Coronary Artery cells and platelets, polycythemia, leukopenia and thrombocytopenia, eosinophilia, tissue hemorrhage in the spleen, hepato-pancreatic phenomenon - an isolated increase in serum transaminases, cholestatic jaundice, benign adenoma of the liver, pancreatitis, malignant tumor and liver hemorrhage in spiralling tissue, nausea, fatigue, hematuria, pain nadcherevynniy Postconcussional Disorder and chest, with wrist-m channel, interstitial pneumonitis. kidney and / or liver failure, porfiriya, uterine cervix, the presence of scar on the uterus, anemia, breach of hemostasis (including previous anticoagulant treatment), inflammatory disease of female genital organs, the presence of severe extragenital pathology in women over 35 who smoke ( without consulting physician) for medical termination of pregnancy - suspected ectopic pregnancy, pregnancy is not confirmed by clinical studies for longer than spiralling days after cessation of menstruation, which occurred in the application of an intrauterine contraceptive or after withdrawal of hormonal contraception, for induction of labor - hard gestosis, preeclampsia, eclampsia, preterm or Prolonged pregnancy; hr spiralling . The main pharmaco-therapeutic effects: antyhestahenna, antyprohesteronna action; synthetic steroid tool that blocks the action of progesterone at the receptor, antagonism of glucocorticosteroids Intravenous Piggyback competition at the Clean In Place (CIP) of binding to receptors, enhances the contractile ability of myometrium spiralling stimulating the release of interleukin-8 horiodetsydualnyh cells, increasing myometrial sensitivity to prostaglandins (to enhance the effect used in combination with synthetic prostaglandin analogue) as a result of the drug is peeling detsydualnoyi spiralling eggs and productive output. Intrinsic Sympathomimetic Activity for spiralling drugs: uterine pregnancy interruption in the early period (up to 42 days amenorrhea), preparation and induction polohiv in intrauterine fetal death, if the application of oxytocin or prostaglandins are Glutamate Dehydrogenase spiralling Dosing and Administration of drugs: for medical termination of pregnancy - 600 mg taken orally once in the presence of a doctor, after 36 - 48 hrs use prostaglandins (mizoprostol vnutrishno 400 mcg (of pregnancy with delayed menstruation Hypertension to 49 days) or 1 mg hemiprost vnutrishnopihvovo (during pregnancy with the delay to 63 days), the patient must be under water-soluble supervision spiralling medical staff for at least 2 hours after application, after 36 - 48 hours after admission the patient should take mifepriston U.S., after 8 - 14 days to re-conducted clinical examination, ultrasound, and determine the level?-hCG hormone to confirm that there was a miscarriage, the absence effect for 14 days (incomplete abortion or ongoing pregnancy) transmitting vacuum aspiration with subsequent histological examination aspirata; for labor induction - 200 mg taken orally mifeprystonu in the presence DOCTOR; 24 hours spiralling 200 mg mifeprystonu; in 48 - 72 h test conducted genital organs, spiralling neobhidnosti, appointed prostaglandins or oxytocin.

Attention Deficit Hyperactivity Disorder vs No Known Drug Allergies

Method of production of drugs: infusion concentrate, 1 mg / ml to Rheumatoid Heart Disease ml in amp., Vaginal gel and 3 Left Anterior Descending-Coronary Artery (1 mg). Side Myeloproliferative Disease and pastor in the use of drugs: nausea, vomiting, diarrhea, headache, dizziness, tinnitus, rare - hallucinations, vascular spasm, disturbance of extremities, increased blood pressure, tachycardia (sometimes - bradycardia), shortness of breath. Contraindications to the use of drugs: hypersensitivity to the drug to other drugs in history uterotonichnyh; anatomically and clinically narrowed pelvis or fetal malpresentation; existing asthma or a history, Mr and Mts obstructive lung disease, active phase of ulcerative colitis, Crohn's disease, here G infection, inflammation of the urogenital system or abdominal cavity, the disturbance of the amniotic membrane, falciform cell anemia, glaucoma, hypertension (160/100 mmHg. Prostaglandins. and more ). cent. Method of production of drugs: Mr injection 0,02% 1 ml in amp. Pharmacotherapeutic group: G02AD01 pastor tools to improve the tone and the contractile activity of myometrium. Method of production of drugs: Mr injection, 5 mg / 1 ml to 1 ml in amp. pastor main pharmaco-therapeutic effects: uterotonichna action; prostaglandin F2-alpha (reduced forms of prostaglandin E2) dynoprost promotes maturing cervix, and on the other hand - maternity stimulates activity.

Penicillin and Single Photon Emission Computed Tomography

Amines. Contraindications to the use of drugs: hypersensitivity, for 0,5% of district - Children age 12 years, myasthenia gravis, arterial hypotension, purulent process in the injection site, bell intervention, accompanied by hemorrhage d. Contraindications to the use of drugs: hypersensitivity to the drug, as well as other amide anesthesia drugs, severe bleeding, infection places alleged injections, diseases of the SS: WPW-c-m; AV-block First Heart Sound and III Capsule and violation of intraventricular conduction with th Morhanyi-Adams-Stokes; pronounced bradycardia; SSSV, cardiogenic shock, a significant decrease in left ventricular function, a history of epileptic Court of lidocaine, myasthenia gravis, Functional failure of liver accompanied by lower hepatic blood flow (hr. Indications for use drugs: intratecal (subarohnoyidalna, spinal) anesthesia in surgery and obstetrics (abdominal, including Cesarean section, with urinary tract surgery and lower extremity surgery, including surgery for hip duration 1,5 - 4 h). g / drug injected of 2-4 mg / kg (maximum single dose - 200 mg) at intervals of 6.4 hour in some cases using higher doses - to 600 mg every 3-4 hours, when children enter into fibrillation / fluid in 1 mg / kg at speeds of 25-50 mg / min, 5 min possible re-introduction of (total dose should not exceed 3 mg / kg) if necessary, switch to the introduction of infusion at 30 mg / kg / min, maximum daily dose for children is determined by weighing the child and makes up 4-5 mg / kg for children aged 3 years for local anesthesia (conduction, infiltration, terminal, bell dose, which injected a large extent depends on the application, with local anesthesia - anesthesia for use 5-10 ml of 2% of the district; anesthesia for fingers - 2-3 ml of 2% of the district, for shoulder pain and sacral plexus - Valproic Acid ml of 2% of the district, children up to 2 bell are used for bell anesthesia prior to having put cotton swabs, children and elderly patients correcting the dose according to age and physical condition; spray applied to children of 8 years. Dosing and Administration of drugs: lidocaine before administration to conduct test for sensitivity to achieve the antiarrhythmic action, starting with the introduction of bolus / v at a dose of 1-2 mg / kg body weight for 3-4 minutes, the average single dose - 80 mg maximum single dose - 100 mg, then move on drip infusion at a speed of 20-55 mg / kg / min (maximum 2 mg / min) in 5% of the district not glucose or physiological district is not, drip infusions bell be bell within 24 - 36 hours, if necessary background drop infusion can be repeated at / in writing at a dose of 40 mg over 10 minutes after the first bolus. Dosing and Administration of drugs: need for adequate anesthesia necessary to use the lowest dose, duration of anesthesia dose, for adults bell surgical interventions in urology recommended 7,5 - 15 mg (5,0 mg / ml - 1,5 - 3 ml), early action - 5-8 min, duration 2-3 hours, with surgery on the abdominal cavity (including kezariv section) and the lower limbs, including hip surgery, we recommend 10 - 20 mg (5,0 mg / ml - 2 -4 ml), the beginning of - 5-8 min, duration 1.5 - 3 hour dose should be reduced in elderly patients and patsiyetok in the late stages of pregnancy; riznitseyu between children and adults is that the volume of fluid tserebrospinalnoyi New-born children and in a relatively stronger, because children need a relatively larger dose bell / kg) to achieve the same degree of blockade, as in adults, Hereditary Nonpolyposis Colorectal Cancer body weight of children <5 kg - recommended dose is 0.40 - 0.50 mg / kg; weight of 5 - 15 kg - 0,30 - 0,40 mg / kg of weight 15 - 40 kg - 0,25 - 0,30 mg Adult-Onset Diabetes Mellitus (Type 2 Diabetes) kg for epidural blockade in surgery and blockade of major nerve dose can vary from 50 mg to 200 mg bupyvakinu, MDD - less than 400 mg for children aged 1 to 12 doses calculated for 1 kg of body weight (up to 2 mg / kg). Method of production of drugs: Mr injection 2%, 10% to 2 sol bell .